Wyeth Takes $58M Loss In Hormone Case To High Court

Law360, New York (March 25, 2011, 6:46 PM EDT) -- Wyeth Pharmaceuticals Inc. petitioned the U.S. Supreme Court on Thursday to hear its appeal of a Nevada jury's $58 million award to three women who claimed the drugmaker's hormone replacement therapy led them to develop breast cancer.

The company's petition for a writ of certiorari calls into question the Nevada Supreme Court's finding that the punitive damages portion of the award was not excessive, and that a court-ordered reduction of the jury's award — which had previously been a whopping $134 million — was enough of...
To view the full article, register now.